Enable medicine is a biotechnology company that develops biological cartography tools to generate cellular maps that help in drug discovery.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 21, 2022 | Series A | $60M | 1 |
General Catalyst
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
General Catalyst
|
Yes | Series A |